Abstract: Training labs for training linemen and other power or utility technicians are disclosed. The training labs can be configured to provide equipotential zone (EPZ) grounding training in overhead and/or underground power scenarios. In some instances, the training labs can be mobile. For example, a mobile training lab can comprise an overhead training side that comprises one more deployable overhead power poles and/or an underground side comprising one or more component cabinets.

Abstract: Training labs for training linemen and other power or utility technicians are disclosed. The training labs can be configured to provide equipotential zone (EPZ) grounding training in overhead and/or underground power scenarios. In some instances, the training labs can be mobile. For example, a mobile training lab can comprise an overhead training side that comprises one more deployable overhead power poles and/or an underground side comprising one or more component cabinets.

Abstract: Systems and methods are provided for retaining or shifting prescription market share. The systems and methods may include receiving a claim from a pharmacy computer, where the claim is associated with a drug requested by a customer, routing the claim to an adjudication engine for benefits processing, and receiving, from the adjudication engine, coverage information for the claim, where the coverage information indicates an amount payable by the customer. The systems and methods may further include determining whether a discount or payment is available to reduce the amount payable by the customer, where the discount or payment is associated with funding by a pharmaceutical manufacturer. If the discount or payment is available, the systems and methods may include transmitting at least a notice of availability of the discount or payment to the pharmacy computer, or automatically adjudicating the claim back to the pharmacy with the reduced amount payable by the customer.

Abstract: While a pharmacist may know of other medications approved by the FDA for the same medical condition, the pharmacist typically does not know what the therapeutically equivalent dose of those products is when compared to the originally prescribed item In addition to this lack of equivalent dosage information, the pharmacist also is unable to determine if any of those other FDA approved items will save the consumer any money. Accordingly, embodiments of the invention can provide pharmacists and/or consumers with equivalent dosage information as well as pricing information for the equivalent dosage. Accordingly, based at least in part on this information, consumers may have an incentive to and may decide to purchase to another prescription drug, thereby shifting market share to a preferred prescription drug or pharmaceutical manufacturer or provider.

Abstract: Embodiments of the present invention may allow for customer discount programs to be implemented for cash customers at one or more pharmacies. In particular, the customer discount programs may be implemented using switch-level transactions between one or more pharmacies and at least one switch provider, and without involvement of PBMs or other third-party payors. Under the customer discount programs, cash customers can be provided with discounts on prescription drug orders without lowering a pharmacy's usual and customary (U&C) prices or other prices upon which third-party reimbursement rates are based. Accordingly, the customer discount programs allow pharmacies to provide discounts to cash customers while maintaining their reimbursement rates on third party-contracts. Additionally, pharmacies that partner with a switch provider in providing these customer discount programs may be provided with rebates from the switch, which may offset at least a portion of the discounts provided to the cash customers.